What does CUSIP 45845P908 represent in this 13F holders report?

CUSIP 45845P908 is the security identifier for 45845P908 - INTERCEPT PHARMACEUTICALS IN - CALL used to aggregate holder disclosures.

How many institutions held 45845P908 - INTERCEPT PHARMACEUTICALS IN - CALL in Q4 2018?

1 institutional investor reported 45845P908 - INTERCEPT PHARMACEUTICALS IN - CALL for Q4 2018. Use the holders table for investor-level position and value details.

INTERCEPT PHARMACEUTICALS IN - CALL

CUSIP: 45845P908

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / CALL
Total 13F shares: 265
Share change: +265
Total reported value: $2,672,000
Price per share: $10077.19
Number of holders: 1
Value change: +$2,672,000
Number of buys: 1

Quarterly Holders Quick Answers

What is CUSIP 45845P908?
CUSIP 45845P908 identifies 45845P908 - INTERCEPT PHARMACEUTICALS IN - CALL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 45845P908:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022

Institutional Holders of INTERCEPT PHARMACEUTICALS IN - CALL as of Q4 2018

As of 31 Dec 2018, INTERCEPT PHARMACEUTICALS IN - CALL was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 265 shares. The largest 1 holders included BOOTHBAY FUND MANAGEMENT, LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.